An experimental treatment called VERVE-102 lowers the amount of "bad" cholesterol in the blood of people with specific ...

Analysis highlights the widespread underuse of statins and cholesterol-lowering therapies among eligible adults in the United ...

For nearly 60 years, doctors have measured cholesterol levels in the blood to identify people at risk of heart disease. But a ...

To lower cholesterol, doctors usually prescribe medicines called statins. Statins work by reducing the amount of cholesterol ...

A new study projects that aligning U.S. cholesterol treatment with clinical guidelines could significantly reduce cardiovascular events nationwide. The study, led by researchers at Baltimore-based ...

While cholesterol levels are commonly used to assess heart disease risk, research shows that another blood ...

By shutting this “off switch,” immune cells called macrophages regain their ability to soak up cholesterol, potentially ...

The placebo-controlled study is aimed at assessing the safety and efficacy of zodasiran in adults and adolescents with HoFH.

Researchers warn thousands of heart attacks and strokes could be prevented if more Americans followed cholesterol medication ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subject in the YOSEMITE Phase 3 clinical trial of zodasiran, the company’s investigational RNA interference ...

"This lack of awareness and treatment may be due to difficulties accessing primary care, low rates of screening in primary care, lack of consensus on screening recommendations, insufficient emphasis ...